DK0839036T3 - Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge - Google Patents

Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge

Info

Publication number
DK0839036T3
DK0839036T3 DK96924834T DK96924834T DK0839036T3 DK 0839036 T3 DK0839036 T3 DK 0839036T3 DK 96924834 T DK96924834 T DK 96924834T DK 96924834 T DK96924834 T DK 96924834T DK 0839036 T3 DK0839036 T3 DK 0839036T3
Authority
DK
Denmark
Prior art keywords
arterial walls
therapy
prevention
lercanidipine
atherosclerotic
Prior art date
Application number
DK96924834T
Other languages
Danish (da)
English (en)
Inventor
Amedeo Leonardi
Rodolfo Testa
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Application granted granted Critical
Publication of DK0839036T3 publication Critical patent/DK0839036T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK96924834T 1995-07-14 1996-06-28 Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge DK0839036T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI951513A IT1275532B (it) 1995-07-14 1995-07-14 Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
PCT/EP1996/002872 WO1997003669A1 (en) 1995-07-14 1996-06-28 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls

Publications (1)

Publication Number Publication Date
DK0839036T3 true DK0839036T3 (da) 2000-01-24

Family

ID=11371972

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96924834T DK0839036T3 (da) 1995-07-14 1996-06-28 Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge

Country Status (19)

Country Link
EP (1) EP0839036B1 (el)
JP (1) JPH11509214A (el)
KR (1) KR19990028741A (el)
CN (1) CN1190345A (el)
AT (1) ATE183644T1 (el)
AU (1) AU690471B2 (el)
CA (1) CA2219501A1 (el)
CZ (1) CZ11698A3 (el)
DE (1) DE69603968T2 (el)
DK (1) DK0839036T3 (el)
ES (1) ES2138359T3 (el)
GR (1) GR3031096T3 (el)
HU (1) HUP9802736A3 (el)
IL (1) IL122302A (el)
IT (1) IT1275532B (el)
NO (1) NO980171L (el)
SK (1) SK4198A3 (el)
WO (1) WO1997003669A1 (el)
ZA (1) ZA965924B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
MX2013004151A (es) 2010-10-12 2013-05-20 Medicines Co Formulaciones de emulsion de clevidipina que contienen agentes antimicrobianos.
SI2654729T1 (sl) 2010-12-24 2016-08-31 Krka, D.D., Novo Mesto Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
JPH11509214A (ja) 1999-08-17
ATE183644T1 (de) 1999-09-15
DE69603968D1 (de) 1999-09-30
IL122302A (en) 2000-08-13
NO980171D0 (no) 1998-01-14
ITMI951513A1 (it) 1997-01-14
IL122302A0 (en) 1998-04-05
KR19990028741A (ko) 1999-04-15
SK4198A3 (en) 1998-05-06
GR3031096T3 (en) 1999-12-31
ES2138359T3 (es) 2000-01-01
EP0839036A1 (en) 1998-05-06
CN1190345A (zh) 1998-08-12
CA2219501A1 (en) 1997-02-06
WO1997003669A1 (en) 1997-02-06
ITMI951513A0 (it) 1995-07-14
HUP9802736A3 (en) 2000-03-28
IT1275532B (it) 1997-08-07
NO980171L (no) 1998-01-14
ZA965924B (en) 1997-01-30
HUP9802736A2 (hu) 1999-03-29
DE69603968T2 (de) 2000-04-06
EP0839036B1 (en) 1999-08-25
CZ11698A3 (cs) 1998-06-17
AU6516496A (en) 1997-02-18
AU690471B2 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
NO975985D0 (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
IS1947B (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
CY2008012I2 (el) Υδροξυεστερες ραπαμυκινης, διαδικασια για τη παρασκευη τους και φαρμακευτικες συνθεσεις περιεχουσες αυτες
NO975984L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
AR017639A1 (es) Procedimiento de la alquilacion directa en una etapa, en las posiciones 7 y 10 simultaneamente de las dos funciones hidroxilos de la 10-desacetilbacatina o de los derivados de esta ultima esterificados en la posicion 13.
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO976128D0 (no) Forbindelser og farmasöytiske blandinger som inneholder dem
DE69914854D1 (de) Sulfoxidderivate und Acetonkomplexe und Verfahren zu ihrer Herstellung
DK0839036T3 (da) Anvendelse af 1,4-dihydropyridinderivater til forebyggelse og terapi af atherosklerotisk nedbrydning af arterievægge
NO179434C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat, og anvendelse av en vannopplöselig monoester som et solubiliserende middel
FR2695826B1 (fr) Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
FR2753449B1 (fr) Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique
ATA900894A (de) Pharmazeutische kompositionen zum vorbeugen und heilen von krebserkrankungen und verfahren zu ihrer herstellung
FR2769311B1 (fr) Nouveaux derives 3,4-diarylthiazolin-2-one ou -2-thione, leurs procedes de preparation et leurs utilisations en therapeutique
IS4809A (is) Taxóíð, efnasmíði þeirra og lyfjasamsetning sem inniheldur þau
NO975365D0 (no) Benzopyraner og farmasöytiske sammensetninger inneholdende dem
TW372962B (en) Pharmaceutical compositions for the prevention, arrest or reversal of atherosclerotic degradation in the arterial walls of a patient
NO308004B1 (no) Nye aminofenylfosfonsyreforbindelser og farmasøytiske sammensetninger inneholdende dem
FR2725720B1 (fr) Derives metalloceniques du diarylethylene, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits derives
NO953322D0 (no) Anvendelse av 1,4-dihydropyridin-3,5-dikarboksylsyreestere som legemidler
IT1285093B1 (it) Composizione farmaceutica per malattie cardiovascolari e renali.
FR2754256B1 (fr) Nouveaux derives 1,2-diarylmethylenes, leurs procedes de preparation, et leurs utilisations en therapeutique
IT1279387B1 (it) Scarpe da ginnastica perfezionate
IT1284139B1 (it) Composizione farmaceutica comprendente un coenzima utile nel trattamento della sindrome da immunodeficenza acquisita
NO179172C (no) Nytt arylpiperidin-derivat og farmasöytiske blandinger som inneholder det